An investigational drug for glioblastoma more than doubled survival and progression-free time compared to standard rates, reported a new study published in Nature Communications. Glioblastoma is the ...
FourStatesHomepage.com on MSN
Pancreatic cancer pill shown to nearly double overall survival time, drug company says
The company reports the drug showed “clinically meaningful improvements” in overall survival.
Welireg significantly improved quality-adjusted survival time over Afinitor in advanced renal cell carcinoma, with a mean Q-TWiST of 17.47 months versus 14.81 months. The relative gain in Q-TWiST with ...
A new independent clinical trial shows that Safeback’s SBX system can increase survival time almost fivefold for avalanche burial victims. There’s one worst case scenario in backcountry skiing that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results